Table 2

Echocardiographic findings of study patients according to clinical events

Patients without events (−)
(N=145)
Patients with events (+)
(N=43)
p Value
LVEDD, cm5.0±0.55.0±0.50.830
LVESD, cm3.1±0.53.1±0.50.947
IVST, cm1.1±0.31.2±0.30.235
PWT, cm1.0±0.21.0±0.20.722
LAVI, ml/m244.5±13.962.0±22.4<0.001
LVEF, %66.2±7.066.1±6.90.921
Mitral inflow-E, m/s0.64±0.160.66±0.170.492
Mitral inflow-A, m/s0.76±0.230.73±0.250.542
Deceleration time, ms240.4±39.7240.8±33.80.964
Isovolumic relaxation time, ms123.7±28.1120.3±23.40.471
PASP, mm Hg28.3±9.430.8±9.50.217
Tissue Doppler velocity
 s′, cm/s6.4±1.55.9±1.70.069
 e′, cm/s4.6±1.74.0±1.70.058
 a′, cm/s7.9±2.07.0±1.70.035
 E/e′ ratio15.2±5.118.3±7.10.002
  • Events comprising the occurrence of new onset of atrial fibrillation, stroke, heart failure, and cardiovascular death.

  • a′, late diastolic septal mitral annular velocity of tissue Doppler; e′, early diastolic septal mitral annular velocity of tissue Doppler; IVST, interventricular septal thickness; LAVI, left atrial volume index; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic dimension; PASP, pulmonary arterial systolic pressure; PWT, posterior wall thickness; s′, systolic septal mitral annular velocity of tissue Doppler.